Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in a Colombian Population.

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in a Colombian Population.

Publication date: Apr 14, 2020

Cognitive impairment has been recognized as an important factor in multiple sclerosis (MS) in the past few years. One brief, reliable and valid tool to assess cognition in MS is the BICAMS, which encompasses the Symbol Digit Modalities Test (SDMT), the California Verbal Learning Test (CVLT II), and the Brief Visuospatial Memory Test – Revised (BVMT-R). Continuing with the international initiative to validate the BICAMS in different countries, here we present the results obtained from the efforts in validating such test in the Colombian population.

100 healthy controls and 50 MS patients participated in the study, group matched for age, education and gender. Subjects completed all three tests of the BICAMS. Instead of the CVLT-II, the Colombian validated form PAMCL (Prueba de Aprendizaje y Memoria con Codificaci’on Libre) was used. Test-retest measures were obtained for 16 patients in order to test for reliability.

Evidence of criterion validity was obtained, MS group performing significantly worse than HC group in all three tests (SDMT: p= .001, d= 0.59; PAMCL: p= .03, d= 0.38; BVMT-R: p

Concepts Keywords
Cognition Neuropsychological tests
Cognitive Impairment Multiple sclerosis
Gender
Multiple Sclerosis
Test
Visuospatial

Semantics

Type Source Name
disease MESH Multiple Sclerosis
disease MESH Cognitive impairment
drug DRUGBANK Pralidoxime

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *